Shanghai Medicilon Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Shanghai Medicilon Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10565
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Shanghai Medicilon Inc (Medicilon) is a drug discovery company that offers integrated services across biology, preclinical, chemistry, and drug discovery processes. The company provides chemistry services such as process development, medicinal chemistry, synthesis chemistry, and analytical chemistry. It offers drug formulation services such as pre-formulation development, research on quality control, analytical development, formulation development, and clinical trial material. Medicilon provides biology services such as crystallization and structural determination, recombinant protein services, discovery biology services, media sales, and computational biology and molecular modeling. The company also provides pharmacology, pharmacokinetic, contract research, bioanalytical and drug safety evaluation services. It caters to pharmaceutical and biotechnology companies. Medicilon is headquartered in Shanghai, China.

Shanghai Medicilon Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 10
SK Biopharma Enters Into Collaboration Agreement With PKU International HealthCare And Shanghai Medicilon 11
Wuxi Beita Enters Into Co-Development Agreement With Shanghai Medicilon For C14 Technologies 12
Shanghai Medicilon Inc – Key Competitors 13
Shanghai Medicilon Inc – Key Employees 14
Shanghai Medicilon Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Recent Developments 16
Other Significant Developments 16
Nov 07, 2018: Shanghai Medicilon:Rare genetic disorder research opens door to novel melanoma therapy 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Key Facts 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Medicilon Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 10
SK Biopharma Enters Into Collaboration Agreement With PKU International HealthCare And Shanghai Medicilon 11
Wuxi Beita Enters Into Co-Development Agreement With Shanghai Medicilon For C14 Technologies 12
Shanghai Medicilon Inc, Key Competitors 13
Shanghai Medicilon Inc, Key Employees 14
Shanghai Medicilon Inc, Other Locations 15
Shanghai Medicilon Inc, Joint Venture 15

List of Figures
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Shanghai Medicilon Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Shanghai Medicilon Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SOCOMEC Group:企業の戦略的SWOT分析
    SOCOMEC Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • GEO Specialty Chemicals Inc:企業の戦略的SWOT分析
    GEO Specialty Chemicals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Kumba Iron Ore Ltd:企業の戦略・SWOT・財務情報
    Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report Summary Kumba Iron Ore Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ranpak Holdings Corp (PACK):企業の財務・戦略的SWOT分析
    Ranpak Holdings Corp (PACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • IBC Solar AG:企業の戦略的SWOT分析
    IBC Solar AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Pareteum Corp (TEUM):企業の財務・戦略的SWOT分析
    Pareteum Corp (TEUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Safe Orthopaedics SA (SAFOR):企業の財務・戦略的SWOT分析
    Summary Safe Orthopaedics SA (Safe Orthopaedics) is medical device company that manufactures and markets devices for spinal surgery. The company’s products comprise implants and surgical instruments. It offers modular cervical cages, percutaneous auto-correction screws, modular anchorage screws, per …
  • Vaxart Inc (VXRT):企業の財務・戦略的SWOT分析
    Vaxart Inc (VXRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • UGI Corp (UGI):石油・ガス:M&Aディール及び事業提携情報
    Summary UGI Corp (UGI) is a holding company providing energy products and services. Through subsidiaries, the company stores, transports, distributes and markets energy products and related services. It distributes propane and butane both domestically and internationally and provides natural gas and …
  • Confused.Com Limited
    Confused.Com Limited - Strategy, SWOT and Corporate Finance Report Summary Confused.Com Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JEA:企業の発電所・SWOT分析2018
    JEA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • Correvio International Sarl-製薬・医療分野:企業M&A・提携分析
    Summary Correvio International Sarl (Correvio International), formerly Iroko Cardio International Sarl, a subsidiary of Cardiome Pharma Corp, healthcare solution provider. The company develops an integrated pharmaceutical platform that offers production, distribution, regulatory, medical, health eco …
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • COWI AS:企業の戦略的SWOT分析
    COWI AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Viking Line ABP:企業の戦略・SWOT・財務情報
    Viking Line ABP - Strategy, SWOT and Corporate Finance Report Summary Viking Line ABP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • KB Securities Vietnam Joint Stock Company:企業の戦略的SWOT分析
    KB Securities Vietnam Joint Stock Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Rockwool International AS:戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sainsbury’s Bank plc:企業の戦略・SWOT・財務情報
    Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report Summary Sainsbury's Bank plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆